Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2007. Start Trial.
Date Value
November 13, 2026 38.72
November 12, 2026 36.38
November 11, 2026 37.76
November 10, 2026 39.03
November 09, 2026 35.31
November 06, 2026 34.57
November 05, 2026 33.47
November 04, 2026 36.96
November 03, 2026 36.69
November 02, 2026 36.25
October 30, 2026 36.30
October 29, 2026 38.55
October 28, 2026 37.78
October 27, 2026 37.37
October 26, 2026 37.22
October 23, 2026 36.56
October 22, 2026 36.19
October 21, 2026 36.30
October 20, 2026 36.08
October 19, 2026 35.58
October 16, 2026 35.07
October 15, 2026 36.96
October 14, 2026 35.02
October 13, 2026 36.30
October 12, 2026 37.42
Date Value
October 09, 2026 37.74
October 08, 2026 39.23
October 07, 2026 39.36
October 06, 2026 39.02
October 05, 2026 39.31
October 02, 2026 39.18
October 01, 2026 39.35
September 30, 2026 39.59
September 29, 2026 77.44
September 28, 2026 77.93
September 25, 2026 81.55
September 24, 2026 81.63
September 23, 2026 82.86
September 22, 2026 84.96
September 21, 2026 83.65
September 18, 2026 81.58
September 17, 2026 81.70
September 16, 2026 84.36
September 15, 2026 83.45
September 14, 2026 84.02
September 11, 2026 85.03
September 10, 2026 90.21
September 09, 2026 92.60
September 08, 2026 93.34
September 04, 2026 95.04

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Viatris, Inc. 1.744
ANI Pharmaceuticals, Inc. 2.568
Corcept Therapeutics, Inc. 9.568
Veru, Inc. 1.256
Johnson & Johnson 8.437

Price to Book Value Related Metrics

PS Ratio 3.733
PEG Ratio -0.0956
Price 30.12
Earnings Yield -2.57%
Market Cap 1.130B
PEGY Ratio -0.0956
Operating PE Ratio 466.84